~~<i id='540D2E86FA'><strike id='540D2E86FA'><tt id='540D2E86FA'><pre id='540D2E86FA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

author：knowledge 2025-09-28 02:30:46 - browse：47

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Statins may not be needed by millions of people, study suggests

focus

explore

knowledge

hotspot

focus

hotspot

AdobeWomenhavealwaysbeenunderrepresentedinmedicalresearch.Anewstudyrevealsthatnotmuchhaschanged,espe

WSS

A protest over insulin prices is seen as a fight for life

Study: Why relieving medical debt did not improve financial outcomes

Study: Why relieving medical debt did not improve financial outcomes

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Padmanee Sharma of MD Anderson at center of lawsuit over credit

The system is set up to fail children with medical complexity

knowledge

knowledge

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why Novartis is going to walk from its acquisition of MorphoSys

After affirmative action ruling, medical educators look to 'holistic review'

'Essentially witchcraft:' A former naturopath takes on the field

Activists slam private health insurers over coverage restrictions

Medicare Advantage plans can’t deny care with AI, CMS warns

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Virtual Event: ASCO Recap, Live!

Duchenne breakthrough therapy leaves behind pioneering families

5 takeaways from STAT's examination of Zynex Medical

explore

Updated Covid vaccine has 54% effectiveness, new study suggests

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Top private equity targets in 2023: cardiology, clinical trials, lasers

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Stephen Quake on the Chan Zuckerberg quest to conquer disease

ALS patient reclaims some autonomy thanks to wearable 'robot'

knowledge

hotspot

focus

hotspot